INNOVATIVE EYEWEAR, INC. Increase (Decrease) in Prepaid Expense
INNOVATIVE EYEWEAR, INC. (LUCY) reported Increase (Decrease) in Prepaid Expense of $335.53 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$234.45K.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $569.98K, a 272.71% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$50.38K, a 260.51% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$53.91K, a 211.33% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for fiscal 2025 was -$28.68K.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for fiscal 2024 was -$16.36K, a 115.88% decline from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for fiscal 2023 was $102.97K, a 27.63% decline from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in prepaid expense for fiscal 2022 was $142.29K, a 228.01% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$234.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $335.53K 10-Q · filed 2026-08-14 | $285.15K derived: sum of 3 quarters · filed 2026-08-14 | $231.25K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $569.98K 10-Q · filed 2026-05-14 | $519.60K derived: sum of 2 quarters · filed 2026-05-14 | $465.70K derived: sum of 3 quarters · filed 2026-05-14 | $388.37K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$50.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$104.28K derived: sum of 2 quarters · filed 2026-03-25 | -$181.61K derived: sum of 3 quarters · filed 2026-08-14 | -$28.68K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$53.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$131.23K derived: sum of 2 quarters · filed 2026-08-14 | $21.69K 10-Q · filed 2025-11-13 | $53.08K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$77.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $75.60K 10-Q · filed 2026-08-14 | $106.98K derived: sum of 3 quarters · filed 2026-08-14 | $155.40K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $152.93K 10-Q · filed 2026-05-14 | $184.31K derived: sum of 2 quarters · filed 2026-05-14 | $232.73K derived: sum of 3 quarters · filed 2026-05-14 | $43.64K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $31.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $79.80K derived: sum of 2 quarters · filed 2026-03-25 | -$109.29K derived: sum of 3 quarters · filed 2026-03-25 | -$16.36K 10-K · filed 2026-03-25 |
| 2024-09-30 | $48.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$140.67K derived: sum of 2 quarters · filed 2025-11-13 | -$47.74K 10-Q · filed 2025-11-13 | -$24.38K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$189.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$96.16K 10-Q · filed 2025-08-14 | -$72.80K derived: sum of 3 quarters · filed 2025-08-14 | -$53.79K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $92.93K 10-Q · filed 2025-05-13 | $116.29K derived: sum of 2 quarters · filed 2025-05-13 | $135.30K derived: sum of 3 quarters · filed 2025-05-13 | $221.27K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $23.36K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $42.37K derived: sum of 2 quarters · filed 2025-03-24 | $128.34K derived: sum of 3 quarters · filed 2025-03-24 | $102.97K 10-K · filed 2025-03-24 |
| 2023-09-30 | $19.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $104.98K derived: sum of 2 quarters · filed 2024-11-12 | $79.62K 10-Q · filed 2024-11-12 | -$25.89K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $85.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $60.60K 10-Q · filed 2024-08-12 | -$44.91K derived: sum of 3 quarters · filed 2024-08-12 | $217.66K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$25.36K 10-Q · filed 2024-05-14 | -$130.87K derived: sum of 2 quarters · filed 2024-05-14 | $131.70K derived: sum of 3 quarters · filed 2024-05-14 | $130.05K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$105.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $157.06K derived: sum of 2 quarters · filed 2024-03-25 | $155.41K derived: sum of 3 quarters · filed 2024-03-25 | $142.29K 10-K · filed 2024-03-25 |
| 2022-09-30 | $262.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $260.92K derived: sum of 2 quarters · filed 2023-11-14 | $247.80K 10-Q · filed 2023-11-14 | $265.18K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$1.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$14.77K 10-Q · filed 2023-08-11 | $2.61K derived: sum of 3 quarters · filed 2023-08-11 | $2.61K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$13.11K 10-Q · filed 2023-05-12 | $4.27K derived: sum of 2 quarters · filed 2023-05-12 | $4.27K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $17.38K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $17.38K derived: sum of 2 quarters · filed 2023-03-24 | $43.38K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $26.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $26.00K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |